Compare GMM & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GMM | VNRX |
|---|---|---|
| Founded | 2017 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.6M | 38.2M |
| IPO Year | 2023 | N/A |
| Metric | GMM | VNRX |
|---|---|---|
| Price | $1.38 | $0.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 40.6K | ★ 2.1M |
| Earning Date | 08-18-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.79 | N/A |
| Revenue | ★ $48,171,048.00 | $1,472,007.00 |
| Revenue This Year | N/A | $55.98 |
| Revenue Next Year | N/A | $420.37 |
| P/E Ratio | $0.81 | ★ N/A |
| Revenue Growth | ★ 41.74 | 14.48 |
| 52 Week Low | $0.94 | $0.22 |
| 52 Week High | $4.75 | $0.94 |
| Indicator | GMM | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 54.16 | 67.56 |
| Support Level | $0.94 | $0.22 |
| Resistance Level | $1.54 | $0.28 |
| Average True Range (ATR) | 0.12 | 0.02 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 75.78 | 81.53 |
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.